ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,372Medicare Part D Prescriptions Filled, Including Refills

Rank: 84 out of 252

$558K Total Retail Price of All Prescriptions

Rank: 84 out of 252

609 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 609 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 8,826 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 467 363 S3 1 5
FUROSEMIDE 374 299 2 7
DONEPEZIL HCL 308 303 3 28
ATORVASTATIN CALCIUM 279 241 4 16
AMLODIPINE BESYLATE 262 224 5 4
POTASSIUM CHLORIDE 261 239 6 8
LISINOPRIL 237 188 7 3
SIMVASTATIN 231 185 8 2
LEVOTHYROXINE SODIUM 223 196 9 1
METOPROLOL TARTRATE 211 183 10 10
NAMENDA 161 161 11 41
METFORMIN HCL 153 103 12 9
WARFARIN SODIUM 153 151 12 14
OMEPRAZOLE 125 99 14 6
GABAPENTIN 121 116 15 11
CLOPIDOGREL 112 111 16 29
TAMSULOSIN HCL 111 104 17 26
PRAVASTATIN SODIUM 105 83 18 12
SERTRALINE HCL 102 69 19 27
ALBUTEROL SULFATE 102 101 19 170
MELOXICAM 100 65 21 20
CITALOPRAM HBR 97 86 22 15
RAMIPRIL 95 95 23 71
MEGESTROL ACETATE 94 94 R 24 138
PLAVIX 92 92 25 43
MIRTAZAPINE 88 75 26 58
SPIRIVA 84 83 27 68
NEXIUM 84 55 27 23
GLIMEPIRIDE 82 66 29 40
ALLOPURINOL 81 71 30 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 67 30 25
LACTULOSE 77 75 32 157
DOXYCYCLINE HYCLATE 76 63 33 92
FAMOTIDINE 76 64 33 59
DIGOXIN 73 73 35 44
LOSARTAN POTASSIUM 71 45 36 24
HYDRALAZINE HCL 70 47 37 95
CLONIDINE HCL 70 48 37 35
ADVAIR DISKUS 69 68 39 63
CARVEDILOL 68 62 40 22
TRAMADOL HCL 65 55 41 17
IPRATROPIUM BROMIDE 62 62 42 330
CYMBALTA 62 57 42 45
LANTUS 60 54 44 55
GLIPIZIDE 59 46 45 52
ATENOLOL 59 58 45 18
HYDROCHLOROTHIAZIDE 58 54 47 13
PROMETHAZINE HCL 56 45 R 48 85
METOPROLOL SUCCINATE 54 49 49 19
ISOSORBIDE MONONITRATE ER 53 47 50 50
OXYCODONE HCL-ACETAMINOPHEN 52 38 S2 51 175
PRIMIDONE 51 51 52 267
ZOLPIDEM TARTRATE 51 40 52 21
LYRICA 50 29 54 66
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.